MedTrace Logo

Adapted Physical Activity, Health-related Quality of Life and Satisfaction With Care in Hospitalized Children

NCT00828217 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 312

Last updated 2010-09-24

No results posted yet for this study

Summary

The aim of this study is to assess the efficacy of adapted physical activity intervention on health-related quality of life and satisfaction with care in hospitalized children and adolescents.

This is a randomized controlled study. The hypothesis is that children practicing adapted physical activity during their hospitalization present a higher health-related quality of life and satisfaction with care than those who do not.

Conditions

  • Hospitalization

Interventions

OTHER

adapted physical activity

one session of adapted physical activity per day (30 minutes each session), during the whole stay at the hospital

Sponsors & Collaborators

  • University of Nancy

    collaborator OTHER

  • Association pour la promotion du sport chez l'enfant malade (APSEM)

    collaborator UNKNOWN

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Pascal Chastagner, MD, PhD · University Hospital of Nancy, Children's Hospital

  • Serge Briançon, Pr · Nancy-University, Paul Verlaine Metz University, Paris Descartes University, EA4360 Apemac, Nancy, France

  • Anne Vuillemin, PhD · Nancy-University, Paul Verlaine Metz University, Paris Descartes University, EA4360 Apemac, Nancy, France

  • Aline Herbinet, PhD · APSEM

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828217 on ClinicalTrials.gov